Hazel M. Robinson

3.7k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

Hazel M. Robinson is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Hazel M. Robinson has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 14 papers in Public Health, Environmental and Occupational Health and 10 papers in Hematology. Recurrent topics in Hazel M. Robinson's work include Genetics and Neurodevelopmental Disorders (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Genomic variations and chromosomal abnormalities (9 papers). Hazel M. Robinson is often cited by papers focused on Genetics and Neurodevelopmental Disorders (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Genomic variations and chromosomal abnormalities (9 papers). Hazel M. Robinson collaborates with scholars based in United Kingdom, Australia and United States. Hazel M. Robinson's co-authors include Gillian Turner, Shannon Wake, T. Webb, Christine J. Harrison, Susan T. Laing, Anthony V. Moorman, Jonathan C. Strefford, Stuart Purvis‐Smith, Gordon Turner and M. W. Partington and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hazel M. Robinson

42 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of fragile X syndrome

1996 530 citations Gillian Turner, T. Webb et al. American Journal of Medical Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hazel M. Robinson United Kingdom	21	1.2k	695	657	644	566	44	2.1k
Susan Moore United Kingdom	20	716 0.6×	204 0.3×	873 1.3×	224 0.3×	317 0.6×	30	2.0k
Christophe Philippe France	30	1.6k 1.3×	190 0.3×	1.5k 2.3×	309 0.5×	285 0.5×	77	2.7k
J. F. Mattéi France	29	1.7k 1.5×	261 0.4×	1.5k 2.3×	125 0.2×	170 0.3×	87	2.9k
M Prieur France	26	1.5k 1.3×	455 0.7×	1.4k 2.1×	184 0.3×	47 0.1×	75	2.6k
Gordana Raca United States	18	1.1k 0.9×	133 0.2×	586 0.9×	88 0.1×	138 0.2×	62	1.7k
Trilochan Sahoo United States	36	2.8k 2.3×	175 0.3×	1.9k 2.9×	426 0.7×	33 0.1×	67	4.1k
Nancy J. Carpenter United States	24	1.2k 1.0×	321 0.5×	1.0k 1.6×	325 0.5×	15 0.0×	72	2.2k
Maria Antonietta Mencarelli Italy	26	1.2k 1.0×	45 0.1×	982 1.5×	354 0.5×	93 0.2×	65	1.9k
J Boué France	22	1.5k 1.3×	103 0.1×	1.4k 2.2×	583 0.9×	42 0.1×	82	2.6k
Daniela del Gaudio United States	18	1.0k 0.8×	128 0.2×	854 1.3×	121 0.2×	55 0.1×	47	1.8k

Countries citing papers authored by Hazel M. Robinson

Since Specialization

Citations

This map shows the geographic impact of Hazel M. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel M. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel M. Robinson more than expected).

Fields of papers citing papers by Hazel M. Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel M. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel M. Robinson. The network helps show where Hazel M. Robinson may publish in the future.

Co-authorship network of co-authors of Hazel M. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel M. Robinson. A scholar is included among the top collaborators of Hazel M. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel M. Robinson. Hazel M. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gardiner, Anne, Helen Parker, Sharron Glide, et al.. (2011). A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia. Leukemia Research. 36(3). 307–310. 9 indexed citations

Strefford, Jonathan C., et al.. (2007). Genome complexity in patients with B-lineage acute lymphoblastic leukaemia revealed by array-based comparative genomic hybridization. ePrints Soton (University of Southampton).

Robinson, Hazel M., Christine J. Harrison, Anthony V. Moorman, Ilse Chudoba, & Jonathan C. Strefford. (2007). Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage–fusion–bridge cycle. Genes Chromosomes and Cancer. 46(4). 318–326. 47 indexed citations

Harrison, Christine J., Anthony V. Moorman, Kerry E. Barber, et al.. (2005). Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. British Journal of Haematology. 129(4). 520–530. 92 indexed citations

Robinson, Hazel M., M Martineau, Rachel L. Harris, et al.. (2005). Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia. Leukemia. 19(4). 564–571. 22 indexed citations

Martineau, Mary, G. Reza Jalali, Kerry E. Barber, et al.. (2005). ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications. Genes Chromosomes and Cancer. 43(1). 54–71. 14 indexed citations

Hain, Richard, Christine J. Harrison, G. Reza Jalali, et al.. (2004). Complex chromosomal abnormalities in utero, 5 years before leukaemia*. British Journal of Haematology. 126(3). 307–312. 14 indexed citations

Harewood, Louise, Hazel M. Robinson, Rachel L. Harris, et al.. (2003). Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia. 17(3). 547–553. 100 indexed citations

Ashley‐Koch, Allison E., Hazel M. Robinson, Anne Glicksman, et al.. (1998). Examination of Factors Associated with Instability of the FMR1 CGG Repeat. The American Journal of Human Genetics. 63(3). 776–785. 42 indexed citations

10.

Turner, Gillian, Hazel M. Robinson, Shannon Wake, Susan T. Laing, & M. W. Partington. (1997). Case finding for the fragile X syndrome and its consequences. BMJ. 315(7117). 1223–1226. 13 indexed citations

11.

Turner, Gillian, T. Webb, Shannon Wake, & Hazel M. Robinson. (1996). Prevalence of fragile X syndrome. American Journal of Medical Genetics. 64(1). 196–197. 530 indexed citations breakdown →

12.

Robinson, Hazel M., et al.. (1996). Informed choice in fragile X syndrome and its effects on prevalence. American Journal of Medical Genetics. 64(1). 198–202. 16 indexed citations

13.

Vries, Bert B.A. de, Hazel M. Robinson, Irene Stolte‐Dijkstra, et al.. (1995). General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation. Journal of Medical Genetics. 32(10). 764–769. 35 indexed citations

14.

McConkie‐Rosell, Allyn, Hazel M. Robinson, Shannon Wake, et al.. (1995). Dissemination of genetic risk information to relatives in the fragile X syndrome: Guidelines for genetic counselors. American Journal of Medical Genetics. 59(4). 426–430. 22 indexed citations

15.

Turner, Gillian, et al.. (1993). Population Screening for Fragile X. Obstetrical & Gynecological Survey. 48(1). 32–33. 4 indexed citations

16.

Turner, Gillian, Hazel M. Robinson, Susan T. Laing, et al.. (1992). Population screening for fragile X. The Lancet. 339(8803). 1210–1213. 62 indexed citations

17.

Mulley, J.C., et al.. (1991). New X‐linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255. American Journal of Medical Genetics. 40(4). 406–413. 50 indexed citations

18.

Partington, M. W., et al.. (1991). Clinical screening score for the fragile X (Martin‐Bell) syndrome. American Journal of Medical Genetics. 38(2-3). 256–259. 38 indexed citations

19.

Sherman, Stephanie L., Gillian Turner, Hazel M. Robinson, & Susan T. Laing. (1988). Investigation of the segregation of the fragile X mutation in daughters of obligate carrier women. American Journal of Medical Genetics. 30(1-2). 633–639. 9 indexed citations

20.

Robinson, Hazel M., et al.. (1980). Hormonal Control of Weight Gain in Infants Recovering from Protein Energy Malnutrition. I. The Effect of Insulin and Metabolic Rate. Pediatric Research. 14(1). 28–33. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact